Study of RP-6306 Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors

ACTIVE_NOT_RECRUITING

#1008, Columbia University, New York

RECRUITING

#1004, Memorial Sloan Kettering Cancer Institute, New York

RECRUITING

#1032, Northwell Health Cancer Institute, New Hyde Park

COMPLETED

#1010, University of Pennsylvania, Philadelphia

RECRUITING

#1027, University of Virginia, Charlottesville

RECRUITING

#1017, Mayo Clinic, Jacksonville

RECRUITING

#1023, START Midwest, Grand Rapids

RECRUITING

#1011, Washington University, St Louis

RECRUITING

#1001, The University of Texas M.D. Anderson Cancer Center, Houston

RECRUITING

#1013, The University of Utah, Salt Lake City

RECRUITING

#1016, Mayo Clinic, Phoenix

COMPLETED

# 1019, UCLA, Westwood Cancer Center, Los Angeles

RECRUITING

#1025, University of California San Francisco, San Francisco

RECRUITING

#1012, Yale, New Haven

RECRUITING

#1002, Dana Farber Cancer Institute, Boston

RECRUITING

#1007, Rhode Island Hospital, Providence

RECRUITING

#1030, Women & Infants Hospital of Rhode Island, Providence

COMPLETED

#2002, The Hospital for Sick Children, Toronto

RECRUITING

#2001, Princess Margaret Cancer Centre, Toronto

COMPLETED

#2003, The Research Institute of the McGill University Health Centre, Montreal

RECRUITING

#4001, Rigshospitalet - Blegdamsvej, Copenhagen

RECRUITING

#3003, Sarah Cannon Research Institute, London